V. BIBLIOGRAPHY

(1) Joranson DE, Gilson AM, Nischik JA, Maurer MA. Fact sheet: Morphine for cancer pain in India. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. 2001 (Monograph).

(2) Joranson DE. Availability of opioid analgesics in Asia: Progress, problems, recommendations. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communications in Cancer Care; Madison, Wisconsin, USA. Prepared for the 16th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; July 5, 2001 (Monograph).

(3) Joranson DE, Gilson AM, Ryan KM, et al. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. Madison, Wisconsin: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center; 2000. (http://www.medsch.wisc.edu/painpolicy/eguide2000/index.html).

(4) Joranson DE, Gilson A. Controlled substances, medical practice, and the law. In: Schwartz HI, ed. Psychiatric Practice Under Fire: the Influence of Government, the Media, and Special Interests on Somatic Therapies. 1st ed. Washington DC: American Psychiatric Press, Inc.; 1994:173-194. (http://www.medsch.wisc.edu/painpolicy/publicat/94appcs.htm).

(5) World Health Organization. Achieving Balance in National Opioids Control Policy: Guidelines for Assessment. Geneva, Switzerland: World Health Organization; 2000. (http://www.who.int/medicines/library/qsm/who-edm-qsm-2000-4/who-edm-qsm-2000-4.htm).

(6) Editorial. The persistent problem with pain. Lancet. 2001;357(9264):1217.

(7) World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability. Second ed. Geneva, Switzerland: World Health Organization; 1996. (http://www.who.int/dsa/cat98/can8.htm).

(8) Rajagopal MR, Joranson DE, Gilson AM. Medical use, misuse, and diversion of opioids in India. Lancet. 2001;358(9276):139-143. (http://www.medsch.wisc.edu/painpolicy/publicat/01lancet/contents.htm).

(9) Rajagopal MR. The challenges of palliative care in India. Natl Med J India. 2001;14(2):65-67.

(10) Blengini C, Joranson DE, Gilson AM. Il consumo di morfina in Europa. S I M G Rivista di Politica Professionale della Medicina Generale. 1998;8:13-16.

(11) Joranson DE. Commentary on proposed modifications to the Italian law on prescribing opioids. University of Wisconsin School of Nursing Television Studio; Madison, Wisconsin, USA. Produced for the meeting "Pain therapy for cancer patients: Rules, training and communication" of the Italian Ministry of Health and the Italian Society of General Practitioners; Rome, Italy; 18 October 2000 (Videocassette).

(12) Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care. In press.

(13) Bennett DS, Carr DB. Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother. 2002;16(1):105-109.

(14) World Health Organization. Assessment of National Capacity for Noncommunicable Disease Prevention and Control: the Report of a Global Survey (WHO/MNC/01.2). Geneva, Switzerland: World Health Organization; 2001.

(15) International Narcotics Control Board. Report of the International Narcotics Control Board for 1995: Availability of Opiates for Medical Needs. New York, NY: United Nations; 1996. (http://www.incb.org/e/ind_ar.htm).

(16) International Narcotics Control Board. Report of the International Narcotics Control Board for 2001. New York, NY: United Nations; 2002. (http://www.incb.org/e/ind_ar.htm).